ARCHIVES

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

NCI Study Finds No Greater Cancer Risk Near Nuclear Plants

September 28, 1990

DCCR Merit Review Of Contracts Finds Most Perform Satisfactorily; 21 Phased Out Early

January 5, 1979

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

CCOPs At Six Months: Sme Exceeding Patient Goals, Most Are Meeting Schedules

March 30, 1984